Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL7542279 | 0.81 | F10 (0.64) | F10F2 | |
| SCHEMBL7412788 | 0.80 | F10 (0.52) | F10F2 | |
| SCHEMBL7412784 | 0.80 | F10 (0.52) | F10F2 | |
| Trifluoroacetic Acid SCHEMBL6223341 | 0.80 | F10 (0.42) | F10 | |
| Trifluoroacetic Acid SCHEMBL6223344 | 0.80 | F10 (0.42) | F10 | |
| Trifluoroacetic Acid SCHEMBL7537550 | 0.76 | F10 (0.47) | F10 | |
| Trifluoroacetic Acid SCHEMBL7407257 | 0.76 | F10 (0.47) | F10 | |
| SCHEMBL7537664 | 0.74 | F10 (0.48) | F10F2 | |
| SCHEMBL7545969 | 0.74 | F10 (0.45) | F10F2 | |
| SCHEMBL6223826 | 0.73 | F10 (0.50) | F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020013310-A1 | Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds | AVENTIS PHARMACEUTICALS PRODUCTS INC. | 2002-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020013310-A1 | Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds | STS, ARSA, F12 | F10 20/4885F2 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.